Get started
PPP

PATHFINDER CELL THERAPY INC

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

PFND chart


Full chart

Key stats


Market capitalization
667.00 USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
—
Revenue (FY)
—
Shares float
‪215.97 M‬
Beta (1Y)
0.00

About PATHFINDER CELL THERAPY INC


Sector
Health Technology
Industry
Medical Specialties
CEO
Richard L. Franklin
Website
pathfindercelltherapy.com
Headquarters
Cambridge
Founded
1990
FIGI
BBG000BHFDR5
Pathfinder Cell Therapy, Inc. is a development stage regenerative medicine company. It focuses on developing a novel cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ-specific cell damage. The company was founded in August 1990 and is headquartered in Cambridge, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PFND is 0.000001 USD — it hasn't changed in the past 24 hours. Watch PATHFINDER CELL THERAPY INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PATHFINDER CELL THERAPY INC stocks are traded under the ticker PFND.
PFND reached its all-time high on Jan 17, 1996 with the price of 11.375000 USD, and its all-time low was 0.000001 USD and was reached on Oct 29, 2021. View more price dynamics on PFND chart.
See other stocks reaching their highest and lowest prices.
PFND stock is 0.00% volatile and has beta coefficient of 0.00. Track PATHFINDER CELL THERAPY INC stock price on the chart and check out the list of the most volatile stocks — is PATHFINDER CELL THERAPY INC there?
Yes, you can track PATHFINDER CELL THERAPY INC financials in yearly and quarterly reports right on TradingView.
No, PFND doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PFND shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PATHFINDER CELL THERAPY INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PATHFINDER CELL THERAPY INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PATHFINDER CELL THERAPY INC stock shows the sell signal. See more of PATHFINDER CELL THERAPY INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.